AFTOGEN OLEO
Commercial- Indications
- Foot and Mouth Disease
Company intelligence / Profile preview
Biogénesis Bagó
Garin, Buenos Aires, Argentina
- Ownership
- Private
- Employees
- ~932
- Development stage
- Commercial
01
Overview
The company produces over 450 million doses of vaccines annually for various animal diseases with more than 90 products and 600 registrations worldwide
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- VaccinesBiologicalsAntiparasiticsAntibiotics
- Industry
- Veterinary
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Collaborations with international institutions for innovative solutionspartnership with Novartis and ELEA Laboratories through Sinergium consortium
Beyond the preview
Go deeper on Biogénesis Bagó.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biogénesis Bagó.